About the Company
We do not have any company description for Anika Therapeutics, Inc. at the moment.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
370
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Anika Therapeutics, Inc.
Q1 2024 Anika Therapeutics Inc Earnings Call
Good evening, ladies and gentlemen, and welcome to Anika's First Quarter 2024 earnings conference call. At this time, all lines are in a listen only mode. Following the presentation, we will ...
Anika Therapeutics, Inc. CEO Dr. Cheryl Blanchard to Present at ...
Anika Therapeutics, Inc. has announced that Dr. Cheryl Blanchard, President and CEO, will present at the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego on March 10, 2025, at 2:30 ...
Anika Therapeutics Inc (ANIK) Q2 2025 Earnings Report Preview: What To ...
Anika Therapeutics Inc (NASDAQ:ANIK) is set to release its Q2 2025 earnings on Jul 30, 2025. The consensus estimate for Q2 2025 revenue is $27.70 million, and the earnings are expected to come in ...
Anika Therapeutics, Inc. Reports 2024 Financial Results with ... - Nasdaq
Anika Therapeutics, Inc. reported its financial results for the fourth quarter and full year 2024, showing a slight overall revenue decrease of 1% for the year, totaling $119.9 million.
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Sold by SG Americas ...
The company has a market cap of $373.28 million, a price-to-earnings ratio of -4.87 and a beta of 0.83. Anika Therapeutics, Inc. has a 12-month low of $16.54 and a 12-month high of $29.11.
Anika Therapeutics, Inc. (ANIK) Stands out Over Competition
Anika Therapeutics, Inc. (NASDAQ:ANIK) has made the cut and will likely pass the $1 billion capitalization mark in the next 5 to 10 years. Big things come in small capitalizations ...
Anika Therapeutics Announces U.S. MONOVISC® License and Supply ...
Anika Therapeutics Announces U.S. MONOVISC® License and Supply Agreement with DePuy Mitek, Inc. Dec 21, 2011 4:20pm Biotech ...
Anika Therapeutics to Host Analyst and Investor Day on September 18 ...
Contacts For Investor Inquiries: Anika Therapeutics, Inc. Sylvia Cheung, 781-457-9000 Chief Financial Officer For Media Inquiries: Pure Communications Sonal Vasudev, 917-523-1418 sonal@w2ogroup.com ...
Anika Therapeutics Announces $30 Million Accelerated Share Repurchase
Anika Therapeutics, Inc. (NASDAQ: ANIK) is a global, integrated orthopedic and regenerative medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients ...
Anika Therapeutics, Inc. (ANIK) Q1 2024 Earnings Call Transcript
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2024 Earnings Conference Call May 8, 2024 5:30 PM ETCompany ParticipantsMark Namaroff - VP of IR, ESG and ...
Anika Therapeutics, Inc. (ANIK) Q3 2024 Earnings Call Transcript
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ETCompany ParticipantsMatt Hall - Director, Corporate ...
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2023 Earnings Call Transcript
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2023 Earnings Call Transcript Published on May 16, 2023 at 6:01 pm by Insider Monkey Transcripts in News, Transcripts ...
Similar Companies
Loading the latest forecasts...